Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A Herpesvirus Protein Selectively Inhibits Cellular mRNA Nuclear Export.

Gong D, Kim YH, Xiao Y, Du Y, Xie Y, Lee KK, Feng J, Farhat N, Zhao D, Shu S, Dai X, Chanda SK, Rana TM, Krogan NJ, Sun R, Wu TT.

Cell Host Microbe. 2016 Nov 9;20(5):642-653. doi: 10.1016/j.chom.2016.10.004.

PMID:
27832591
2.

Oncolytic virotherapy for ovarian cancer.

Li S, Tong J, Rahman MM, Shepherd TG, McFadden G.

Oncolytic Virother. 2012 Aug;1:1-21.

3.

Regulation of mRNA trafficking by nuclear pore complexes.

Bonnet A, Palancade B.

Genes (Basel). 2014 Sep 2;5(3):767-91. doi: 10.3390/genes5030767. Review.

4.

Vesiculoviral matrix (M) protein occupies nucleic acid binding site at nucleoporin pair (Rae1 • Nup98).

Quan B, Seo HS, Blobel G, Ren Y.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9127-32. doi: 10.1073/pnas.1409076111. Epub 2014 Jun 9.

5.

Nuclear trafficking in health and disease.

Mor A, White MA, Fontoura BM.

Curr Opin Cell Biol. 2014 Jun;28:28-35. doi: 10.1016/j.ceb.2014.01.007. Epub 2014 Feb 11. Review.

6.

Viral subversion of nucleocytoplasmic trafficking.

Yarbrough ML, Mata MA, Sakthivel R, Fontoura BM.

Traffic. 2014 Feb;15(2):127-40. doi: 10.1111/tra.12137. Epub 2013 Dec 2. Review.

7.

Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export.

Kuss SK, Mata MA, Zhang L, Fontoura BM.

Viruses. 2013 Jul 18;5(7):1824-49. doi: 10.3390/v5071824. Review.

8.

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Hastie E, Grdzelishvili VZ.

J Gen Virol. 2012 Dec;93(Pt 12):2529-45. doi: 10.1099/vir.0.046672-0. Epub 2012 Oct 10. Review.

9.

Inclusion bodies are a site of ebolavirus replication.

Hoenen T, Shabman RS, Groseth A, Herwig A, Weber M, Schudt G, Dolnik O, Basler CF, Becker S, Feldmann H.

J Virol. 2012 Nov;86(21):11779-88. doi: 10.1128/JVI.01525-12. Epub 2012 Aug 22.

10.

Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.

Heiber JF, Xu XX, Barber GN.

Chin J Cancer. 2011 Dec;30(12):805-14. doi: 10.5732/cjc.011.10205. Epub 2011 Nov 4. Review.

11.

Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Gerlier D, Lyles DS.

Microbiol Mol Biol Rev. 2011 Sep;75(3):468-90, second page of table of contents. doi: 10.1128/MMBR.00007-11. Review.

12.

Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Marozin S, De Toni EN, Rizzani A, Altomonte J, Junger A, Schneider G, Thasler WE, Kato N, Schmid RM, Ebert O.

PLoS One. 2010 Jun 7;5(6):e10988. doi: 10.1371/journal.pone.0010988.

13.

Characterization of the role of the tumor marker Nup88 in mitosis.

Hashizume C, Nakano H, Yoshida K, Wong RW.

Mol Cancer. 2010 May 24;9:119. doi: 10.1186/1476-4598-9-119.

Supplemental Content

Support Center